title: Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.
abstract: A 32-year-old man with chronic hepatitis B who was treated with pegylated interferon alpha-2b once a week, developed widespread psoriasis 4 weeks after the beginning of the treatment. There was no history of psoriasis. The treatment was stopped and gradually the eruption vanished. Thereafter, the patient was treated with lamivudine successfully without dermatological or other sequelae.
authors.affiliation: Department of Internal Medicine, Hippocration General Hospital, Athens, Greece. ketik@teledomenet.gr
authors.forename: Ioannis
authors.initials: I
authors.lastname: Ketikoglou
authors.forename: Stelios
authors.initials: S
authors.lastname: Karatapanis
authors.forename: Ioannis
authors.initials: I
authors.lastname: Elefsiniotis
authors.forename: Georgia
authors.initials: G
authors.lastname: Kafiri
authors.forename: Antonios
authors.initials: A
authors.lastname: Moulakakis
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011092:Polyethylene Glycols; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b